The slip
PARKINSON RECEIPTno. 16392
31 Oct 2026, 16:13 UTCdopamine neurons, braak
predictionMMP24 in dopamine neurons tracks Braak Lewy-body stage
registered54c451f2d2dd39a7
discovery-0.42 p=0.255 n=9
replication-0.68 p=0.045 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.42, p 0.255)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8a51ae1dd688956411e23ac4…
follows a5f960122801…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 16392: MMP24 in dopamine neurons, braak
- power
- full sample -0.51 (p 0.031, n 18), 95% CI -0.79 to -0.05. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.51 (p 0.031, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.64 (p 0.0045, n 18). not the mix.
- skeptic
- leave-one-out range -0.66 to -0.45, sign flips 0; without severely affected donors -0.51 (p 0.031, n 18). robust.
- cell type
- strongest in microglia: -0.61 (p 0.0075, n 18) vs -0.51 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MMP24 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up MMP24 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.25 p 0.374 (needs p < 1.4e-4)